Thermo Fisher Scientific CDR (CAD Hedged) (TMO) - Analysis

19.51000 CAD

0.34

1.71%

Last update Feb 10, 3:25 PM EST

Market closed

Day range

19.51000

19.51000

19.92000

Previous close

19.85000

Open

19.92000

Access this stock data via API

Thermo Fisher Scientific CDR (CAD Hedged)

19.51

0.34

1.71%

Analysis

Revenue estimate	Next quarter (Mar 2026)	Next year (Dec 2026)
Number of Analysts	13	25
Avg. estimate	11.03B	46.52B
Low estimate	10.87B	46.01B
High estimate	11.25B	46.93B
Last year sales	10.36B	44.26B
Sales growth	0.06	0.05

Access /revenue_estimate data via our API — starting from the Ultra plan.

EPS revisions	Next quarter (Mar 2026)	Next year (Dec 2026)
Up last 7 days	0	0
Up last 30 days	0	0
Down last 7 days	0	0
Down last 30 days	0	0

Access /eps_revisions data via our API — starting from the Ultra plan.

Analyst ratings

Firm	Date	Action
William Blair	Aug 19, 2025	Initiates
Bernstein	Jan 08, 2024	Downgrade
Wolfe Research	Dec 13, 2023	Initiates
Keybanc	Oct 26, 2023	Downgrade
Morgan Stanley	Oct 28, 2021	Reinstates
Citigroup	Dec 16, 2020	Downgrade
Keybanc	Nov 10, 2020	Initiates
Atlantic Equities	Sep 30, 2020	Initiates
Cleveland Research	Jul 15, 2020	Upgrade
Cleveland Research	Oct 18, 2018	Downgrade
Leerink Swann	Nov 10, 2016	Assumes
JP Morgan	Sep 22, 2016	Assumes
Cleveland Research	Sep 09, 2016	Downgrade
Jefferies	Apr 29, 2016	Downgrade
Deutsche Bank	Jan 06, 2016	Initiates
UBS	Mar 10, 2015	Initiates
BTIG	Oct 03, 2014	Initiates
Wells Fargo	Oct 05, 2012	Upgrade
WallachBeth Capital	Aug 09, 2012	Initiates

Access /analyst_ratings/light data via our API — starting from the Ultra plan.